We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

77 hedge funds and large institutions have $141M invested in BioTelemetry, Inc. in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $2.46M | Put options by funds: $1.68M

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

3% more funds holding

Funds holding: 7577 (+2)

8% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 24

20% less capital invested

Capital invested by funds: $176M → $141M (-$35.3M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
77
Holders Change
+2
Holders Change %
+2.67%
% of All Funds
2.24%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
20
Increased
26
Reduced
24
Closed
18
Calls
$2.46M
Puts
$1.68M
Net Calls
+$778K
Net Calls Change
-$1.5M
Name Holding Trade Value Shares
Change
Change in
Stake
CPIM
1
Columbia Partners Investment Management
Virginia
$18.8M +$4.55M +487,996 +26%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$10.7M +$114K +12,180 +0.9%
SC
3
Sophrosyne Capital
New York
$9.78M +$2.04M +218,400 +22%
SFM
4
Systematic Financial Management
New Jersey
$8.88M +$5.61M +600,560 +116%
CAM
5
Cortina Asset Management
Wisconsin
$7.78M +$9.15M +980,060 New
TAM
6
THB Asset Management
Connecticut
$6.45M +$7.59M +812,880 New
New York State Common Retirement Fund
7
New York State Common Retirement Fund
New York
$6.21M +$4.52M +484,000 +162%
Vanguard Group
8
Vanguard Group
Pennsylvania
$5.33M +$302K +32,400 +5%
Renaissance Technologies
9
Renaissance Technologies
New York
$5.27M -$1.97M -211,300 -24%
BIT
10
BlackRock Institutional Trust
California
$4.9M +$496K +53,185 +9%
EA
11
Emerald Advisers
Pennsylvania
$4.15M +$2.51M +268,430 +105%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$4.04M +$1.22M +130,559 +35%
BIM
13
Bogle Investment Management
Massachusetts
$3.75M -$141K -15,100 -3%
Fuller & Thaler Asset Management
14
Fuller & Thaler Asset Management
California
$3.66M -$110K -11,750 -2%
BCM
15
Bridgeway Capital Management
Texas
$3.65M
Allianz Asset Management
16
Allianz Asset Management
Germany
$3.43M +$1.44M +154,713 +56%
Morgan Stanley
17
Morgan Stanley
New York
$2.92M -$1.57M -168,077 -31%
TC
18
TFS Capital
Pennsylvania
$2.71M -$505K -54,140 -14%
DCM
19
DAFNA Capital Management
California
$1.71M -$867K -92,920 -30%
CC
20
Cannell Capital
Wyoming
$1.7M +$2M +214,082 New
DCM
21
Driehaus Capital Management
Illinois
$1.65M +$1.24M +133,105 +180%
Arrowstreet Capital
22
Arrowstreet Capital
Massachusetts
$1.42M +$1.67M +179,137 New
AWMDMG
23
Austin W. Marxe & David M. Greenhouse
New York
$1.39M +$233K +25,000 +17%
EIM
24
Essex Investment Management
Massachusetts
$1.02M +$65.6K +7,025 +6%
HCM
25
Highbridge Capital Management
New York
$994K +$1.17M +125,190 New

BEAT Hedge Fund Activity: Q4 2013 in Review

77 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q4 2013, worth a combined $141M — down 20% from $176M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new BEAT positions and 18 closed out — a net gain of 2 holders — while 26 added to existing stakes and 24 trimmed.

The largest buyer was Cortina Asset Management, opening a new position worth an estimated $9.15M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $9.9M sold.

  • 77 institutional investors held BioTelemetry, Inc. (BEAT) as of Q4 2013, up from 75 in Q3 2013.
  • Funds reported $141M of BioTelemetry, Inc. stock for Q4 2013, down 20% quarter-over-quarter.
  • 20 funds opened new BioTelemetry, Inc. positions in Q4 2013 and 18 closed out, a net change of +2 holders.
  • The largest BioTelemetry, Inc. buyer in Q4 2013 was Cortina Asset Management, an estimated $9.15M added.
  • The largest BioTelemetry, Inc. seller in Q4 2013 was Balyasny Asset Management, an estimated $9.9M sold.

Based on aggregated 13F filings for Q4 2013.